These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35193437)

  • 41. 2-Phenylcyclopropylmethylamine (PCPMA) as a privileged scaffold for central nervous system drug design.
    Li H; Cheng J
    Bioorg Med Chem Lett; 2024 Mar; 101():129654. PubMed ID: 38360418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Industrial medicinal chemistry insights: neuroscience hit generation at Janssen.
    Tresadern G; Rombouts FJR; Oehlrich D; Macdonald G; Trabanco AA
    Drug Discov Today; 2017 Oct; 22(10):1478-1488. PubMed ID: 28669605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An overview of molecular hybrids in drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2016; 11(3):281-305. PubMed ID: 26727036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An overview of spirooxindole as a promising scaffold for novel drug discovery.
    Zhou LM; Qu RY; Yang GF
    Expert Opin Drug Discov; 2020 May; 15(5):603-625. PubMed ID: 32106717
    [No Abstract]   [Full Text] [Related]  

  • 45. Syntheses and medicinal chemistry of azepinoindolones: a look back to leap forward.
    Kadagathur M; Patra S; Sigalapalli DK; Shankaraiah N; Tangellamudi ND
    Org Biomol Chem; 2021 Jan; 19(4):738-764. PubMed ID: 33459333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry.
    Mäder P; Kattner L
    J Med Chem; 2020 Dec; 63(23):14243-14275. PubMed ID: 32870008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current Fragment-to-lead Approaches Starting from the 7-azaindole: The Pharmacological Versatility of a Privileged Molecular Fragment.
    Marcos Santos L; da Silveira NJF
    Curr Top Med Chem; 2023; 23(22):2116-2130. PubMed ID: 37461366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ROCK: the Roche medicinal chemistry knowledge application - design, use and impact.
    Mayweg A; Hofer U; Schnider P; Agnetti F; Galley G; Mattei P; Lucas M; Boehm HJ
    Drug Discov Today; 2011 Aug; 16(15-16):691-6. PubMed ID: 21439402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective.
    Karawajczyk A; Giordanetto F; Benningshof J; Hamza D; Kalliokoski T; Pouwer K; Morgentin R; Nelson A; Müller G; Piechot A; Tzalis D
    Drug Discov Today; 2015 Nov; 20(11):1310-6. PubMed ID: 26429298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery.
    Rashidi MR; Soltani S
    Expert Opin Drug Discov; 2017 Mar; 12(3):305-316. PubMed ID: 28095715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Into the Fray! A Beginner's Guide to Medicinal Chemistry.
    Veale CGL
    ChemMedChem; 2021 Apr; 16(8):1199-1225. PubMed ID: 33591595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein-protein interaction inhibitors: advances in anticancer drug design.
    Ferreira LG; Oliva G; Andricopulo AD
    Expert Opin Drug Discov; 2016 Oct; 11(10):957-68. PubMed ID: 27554357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies.
    Ren Y; Ma Y; Cherukupalli S; Tavis JE; Menéndez-Arias L; Liu X; Zhan P
    Eur J Med Chem; 2020 Nov; 206():112714. PubMed ID: 32949990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time.
    Ertl P; Altmann E; McKenna JM
    J Med Chem; 2020 Aug; 63(15):8408-8418. PubMed ID: 32663408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applications of oxetanes in drug discovery and medicinal chemistry.
    Huang G; Hucek D; Cierpicki T; Grembecka J
    Eur J Med Chem; 2023 Dec; 261():115802. PubMed ID: 37713805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The structural modification of natural products for novel drug discovery.
    Yao H; Liu J; Xu S; Zhu Z; Xu J
    Expert Opin Drug Discov; 2017 Feb; 12(2):121-140. PubMed ID: 28006993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patents of bio-active compounds based on computer-aided drug discovery techniques.
    Prado-Prado F; Garcia-Mera X; Rodriguez-Borges JE; Concu R; Perez-Montoto LG; Gonzalez-Diaz H; Duardo-Sanchez A
    Front Biosci (Elite Ed); 2013 Jan; 5(2):399-407. PubMed ID: 23276997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.